Purnanand D. Sarma, PhD


Purnanand D. Sarma, PhD. is former CEO of TARIS® and has more than 20 years of pharmaceutical experience in large, medium and small companies. Previously he was General Manager and Vice President of Worldwide Drug Delivery Technologies of CIMA LABS, Inc., a subsidiary of Cephalon (now Teva), and Vice President of Pharmaceutical Development at Nektar Therapeutics (NASDAQ:NKTR). Dr. Sarma started his career at SmithKline Beecham Pharmaceuticals. He earned a Ph.D. in Pharmaceutics from the University of Minnesota and a B.S. in Pharmacy from Andhra University in Visakhapatnam, India.

About Us

Ohm Oncology has been established by drug development professionals with years of experience in the ‘bench to bed-side journey’ of a drug. Particularly, the team specializes in oncology and neoplasms with a vision to bring forth novel drugs for the management of treatment-refractory and difficult to treat cancers.

Where we are

2405 Robert Browning St.

Austin, TX 78723

P : +1-408-218-9330

Message us


Copyrights © 2019 Ohm Oncology
All Rights Reserved